Form 8-K - Current report:
SEC Accession No. 0001193125-25-004065
Filing Date
2025-01-10
Accepted
2025-01-10 07:01:39
Documents
15
Period of Report
2025-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d904622d8k.htm   iXBRL 8-K 33020
2 EX-99.1 d904622dex991.htm EX-99.1 19652
6 GRAPHIC g904622g0110045741416.jpg GRAPHIC 2669
  Complete submission text file 0001193125-25-004065.txt   190640

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20250109.xsd EX-101.SCH 2510
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20250109_lab.xml EX-101.LAB 18664
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20250109_pre.xml EX-101.PRE 11671
17 EXTRACTED XBRL INSTANCE DOCUMENT d904622d8k_htm.xml XML 3906
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 25520347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)